177 related articles for article (PubMed ID: 30062986)
1. Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania.
Martin D; Wiegand R; Goodhew B; Lammie P; Mkocha H; Kasubi M
Am J Trop Med Hyg; 2018 Oct; 99(4):937-939. PubMed ID: 30062986
[TBL] [Abstract][Full Text] [Related]
2. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
Lupenza ET; Gasarasi DB; Minzi OM
PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
[TBL] [Abstract][Full Text] [Related]
5. Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis--a rapid assessment methodology to assess impact.
Mohammed KA; Deb RM; Stanton MC; Molyneux DH
Parasit Vectors; 2012 Dec; 5():299. PubMed ID: 23259465
[TBL] [Abstract][Full Text] [Related]
6. Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
Endeshaw T; Taye A; Tadesse Z; Katabarwa MN; Shafi O; Seid T; Richards FO
Pathog Glob Health; 2015; 109(7):344-51. PubMed ID: 26878935
[TBL] [Abstract][Full Text] [Related]
7. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
Wilson NO; Badara Ly A; Cama VA; Cantey PT; Cohn D; Diawara L; Direny A; Fall M; Feeser KR; Fox LM; Kabore A; Seck AF; Sy N; Ndiaye D; Dubray C
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005198. PubMed ID: 27926918
[TBL] [Abstract][Full Text] [Related]
9. Filariasis in Africa--treatment challenges and prospects.
Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.
Griswold E; Eigege A; Ityonzughul C; Emukah E; Miri ES; Anagbogu I; Saka YA; Kadiri S; Adelamo S; Ugbadamu P; Ikogho C; Richards FO
Am J Trop Med Hyg; 2018 Aug; 99(2):396-403. PubMed ID: 29943709
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.
Fimbo AM; Mnkugwe RH; Mlugu EM; Kunambi PP; Malishee A; Minzi OMS; Kamuhabwa AAR; Aklillu E
Infect Dis Poverty; 2024 Jun; 13(1):44. PubMed ID: 38867265
[TBL] [Abstract][Full Text] [Related]
14. Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
Mnkai J; Marandu TF; Mhidze J; Urio A; Maganga L; Haule A; Kavishe G; Ntapara E; Chiwerengo N; Clowes P; Horn S; Mosoba M; Lazarus W; Ngenya A; Kalinga A; Debrah A; Rieß F; Saathoff E; Geldmacher C; Hoerauf A; Hoelscher M; Chachage M; Kroidl I
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010044. PubMed ID: 35857778
[TBL] [Abstract][Full Text] [Related]
15. Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
Minetti C; Tettevi EJ; Mechan F; Prada JM; Idun B; Biritwum NK; Osei-Atweneboana MY; Reimer LJ
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006994. PubMed ID: 30608931
[TBL] [Abstract][Full Text] [Related]
16. Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.
Willis GA; Kearns T; Mayfield HJ; Sheridan S; Thomsen R; Naseri T; David MC; Engelman D; Steer AC; Graves PM; Lau CL
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011549. PubMed ID: 37607196
[TBL] [Abstract][Full Text] [Related]
17. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
[TBL] [Abstract][Full Text] [Related]
18. No secondary impact of ivermectin mass drug administration for onchocerciasis elimination on the prevalence of scabies in northwestern Ethiopia.
Yirgu R; Middleton J; Fekadu A; Davey G; Bremner S; Jones CI; Cassell JA
Trans R Soc Trop Med Hyg; 2024 Feb; 118(2):110-117. PubMed ID: 37665766
[TBL] [Abstract][Full Text] [Related]
19. Progress on elimination of lymphatic filariasis in Sierra Leone.
Koroma JB; Sesay S; Conteh A; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y
Parasit Vectors; 2018 Jun; 11(1):334. PubMed ID: 29866207
[TBL] [Abstract][Full Text] [Related]
20. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]